Microbiological, clinical and epidemiological aspects of Streptococcus pneumoniae isolates recovered over two years;Aspectos microbiológicos y clinicoepidemiológicos de los aislados de Streptococcus pneumoniae durante dos años

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 22, Issue 1, 2004, Pages 13-17

  Viciana, Ma Isabel ^a,c   García López, Ma Victoria ^a   Mariscal, Alberto ^b   Sánchez Bernal, Ma Antonia ^a   Clavijo, Encarnación ^a   Martín, Elena ^a   Rodríguez Ortega, Rocío ^a   Pinedo, Alfonso ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c NONE   (Spain)

Author keywords

Antibiotic resistance; Epidemiology; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; SEROTYPE; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 12144291235     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056686     Document Type: Article

References (27)

1. Mensa J, Gatell JM, Jiménez de Anta M, Prats G, Domínguez-Gil A. Guía de terapéutica antimicrobiana. 11.a ed. Barcelona: Masson, 2001.
2. Klugman K. Epidemiology, control and treatment of multirresistant pneumococci. Drugs 1996;52(2 Suppl):42-6.
3. Haglund L, Istre G, Picket D, Welch D, Fine D. The pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: Emergence of high level penicilin resistant and multiple antibiotic resistance. J Infect Dis 1993;168:15362-6.
4. Liñares J, Pallarés R, Alonso T, Pérez JL, Ayats J, Gudiol F, et al. Trends in antimicrobial resistance of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992;15:106-11.
5. Pallarés R, Liñares J, Vadillo M. Resistance to penicilin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
6. Fenoll A, Jado I, Vicioso D, Casal J. Evolucion of Streptococcus pneumoniae serotipes and antibiotic resistance in Spain: Update. J Clin Microbiol 1998; 36:3447-54.
7. Baquero F. Pneumococcal resistance to (β-lactams antibiotics: A global geographic overview. Microbiol Drug Resistant 1995;1:115-20.
8. Smith JM, Dowson CG, Spratt BG. Localized sex in bacteria. Nature 1991;349:29.
9. Garcia Leoni ME, Cercenado E, Rodeño P, Bernardo de Quirós J, Martinez-Hernández D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicilin: A prospective microbiological and clinical study. Clin Inf Dis 1992; 14:427-35.
10. Scott J, Hall A, Dagan R, Dixon J, Eykyn S, Fenoll A, et al. Serogroup specific epidemiology of Streptococcus pneumoniae: Associations with age, sex and geography in 7000 episodes of invasive disease. Clin Inf Dis 1996;22:973-81.
11. Garau J, Aguilar L, Rodríguez-Creixems M, Dal-Ré R, Pérez Trallero E, Rodríguez M, et al. Influencia de la comorbilidad y la gravedad en la evolución clinica de la neumonía neumocócica bacteriémica tratada con (β-lactámicos en monoterapia. J Chemotherapy 1999;11:266-72.
12. Metlay J, Hofmann J, Ceetron M, Fine M, Farley M, Whitney C, et al. Impact of penicilin susceptibility on medical outcomes for adult patients with bacteriemic pneumococcal pneumonia. Cli Inf Dis 2000;30:520-8.
13. Appelbaum P. Microbiological and pharmacodinamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae. Clin Inf Dis 2000;31(2 Suppl):29-34.
14. Gillespie H, O'Neil A, Whiting G. Detection of penicilin susceptibility in Streptococcus pneumoniae by pbp 2b PCR Restriction Fragment Length Polymorphism Analysis. J Clinic Microbiol 1999;37:157-60.
15. Simarro E, Ruiz J. Resistencia de Streptococcus pneumoniae a los antibióticos. Rev Esp Quimioterap 1998;11:353-5.
16. Fenoll A, Martin Bourgon C, Muñoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-89. Rev Inf Dis 1991;13:56-60.
17. Jalal H, Organji S, Reynolds J, Benett D, O'Masson E, Milliar M. Determination of penicilin susceptibility of Streptococcus pneumoniae using the polymerase chain reaction. J Clin Pathol 1997;50:45-50.
18. Gomez-Lus R, Adrián F, Gómez-Lus S, Rubio-Calvo MC. Presión selectiva antibiótica y resistencia en infecciones por Streptococcus pneumoniae. Med Clin 1998;110:3-8.
19. Breiman R, Butler JC, Tenover FC, Elliot JA, Facklam R. Emergence of drug resistant pneumococcal infections in the United States. JAMA 1994; 271:1831-5.
20. Fiore A, Moroney J, Farley M, Harrison L, Patterson J, Jorgensen J, et al. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Inf Dis 2000;30:71-7.
21. Gómez-Lus R, Granizo J, Aguilar L, Bouza E, Gutiérrez A, García de Lomas J, and the Spanish Surveillance Group For Respiratory pathogens. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? J Clin Microbiol 1999;37:3384-6.
22. Jacobs MR. Increase importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatric Infect Dis J 1996;15:940-3.
23. Del Castillo F, Baquero F, García Perea A. Influence of recient antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatric Infect Dis J 1998;17:94-7.
24. Catalán MJ, Fernández JM, Vázquez A, Varela de Seijas E, Suárez A, Bernaldo de Quirós JC. Failure of cefotaxime in the tratment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Inf Dis 1994;18:766-9.
25. John CH. Treatment failure with use of a third-generation cephalosporin for penicilin-resistant pneumococcal meningitis: Case report and review. Clin Inf Dis 1994;18:188-93.
26. García de Lomas y Grupo Español para Vigilancia de Patógenos Respiratorios. Situación epidemiológica actual y resistencia de los patógenos respiratorios en España. Med Clin (Barc) 1998;10:44-52.
27. Marco F, Bouza E, García de Lomas J, Aguilar L, y el Grupo Español de Vigilancia de Patógenos Respiratorios. Streptococcus pneumoniae in community-adquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. J Antimicrobial Chem 2000;46:557-64.